+1 877 705 1914• 24 / 7
HIPAA Compliant
ISO 27001 Certified

Actively Recruiting

Age: 18Years +
All Genders
ID03492151

Study of Confocal Laser Endomicroscopy Imaging for Diagnosis of Pancreatic Cystic Lesions

Led by Ohio State University Comprehensive Cancer Center · Updated on 2026-10-13

500

Participants Needed

10

Research Sites

N/A

Total Duration

AI-Summary

What This Trial Is About

Researchers are observing patients with pancreatic cysts to assess the use of confocal laser endomicroscopy nCLE as an imaging biomarker for diagnosis. The study involves patients referred to academic centers for endoscopic ultrasound EUS evaluation of pancreatic cystic lesions PCL who meet specific criteria. The goal is to improve the accuracy of PCL diagnosis and risk stratification, particularly for intraductal papillary mucinous neoplasms IPMNs. Participants undergo EUS-guided nCLE imaging first, followed by EUS-guided fine needle aspiration FNA to collect cyst fluid. The fluid is analyzed for carcinoembryonic antigen CEA, cytology, and molecular markers as part of standard care. Based on multidisciplinary tumor board recommendations, some patients may proceed to surgery, where surgical histopathology acts as the gold standard for diagnosis. During the study, participants are evaluated using these imaging and fluid analysis procedures. Researchers measure the accuracy of diagnosis and risk stratification over 48 months, also assessing imaging quality. The study involves obtaining patient consent and collecting data from procedures and surgical outcomes when applicable, continuing until the study completion date in 2028.

CONDITIONS

Brief Title

Confocal Laser Endomicroscopy as an Imaging Biomarker for the Diagnosis of Pancreatic Cystic Lesions

Research Team

M

Megan Fry

D

Diana Burke

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here